News Related to Mucosal-Associated Invariant T Cell

Related coverage linked through entity extraction aliases.

Engineered Listeria Bacteria Shows Promise as Cancer Immunotherapy

Feb 13, 2026

Researchers have developed attenuated Listeria bacteria therapies that boost innate immune cells to fight cancer. Two approaches target colorectal cancer and pediatric leukemia, with FDA clearance expected soon for trials in children.

Pluri Secures China Patent for Large-Scale Immune Cell Manufacturing Technology

Feb 18, 2026

Pluri Inc. receives patent grant from China National Intellectual Property Administration for its proprietary 3D immune cell expansion and activation technology, expanding global IP protection across U.S., China, Japan, Korea, Australia and Israel.